Clarivate Plc (CLVT)
AI stock analysis · Information Technology Services · Last analyzed Jul 8, 2026
Clarivate's investment thesis rests almost entirely on its anomalously low forward P/E of 2.9x and PEG of 0.18, implying the market is pricing in deep pessimism that could reverse if profitability inflects — management has beaten EPS estimates in each of the last 4 quarters, suggesting improving cost discipline. However, the company remains loss-making on a trailing basis, revenue is contracting at -1.4% YoY, and analyst consensus is a tepid Hold with limited coverage. The primary risk is that the low valuation is a value trap driven by structural revenue erosion rather than a mispriced recovery.
- Q1/Q2 2025 earnings releases — any acceleration in EPS improvement or return to revenue growth would serve as a powerful re-rating catalyst given the deeply depressed valuation
- Strategic portfolio restructuring or asset divestitures that could streamline operations, reduce debt, and demonstrate a credible path to GAAP profitability
- Expansion of analyst coverage beyond the current small group — broader institutional attention could compress the risk premium embedded in the current ~$2 stock price
- Revenue contraction risk: current -1.4% YoY decline could accelerate if core data and analytics segments face further client churn, potentially invalidating the ultra-low forward P/E thesis
- Debt burden and capital structure risk: loss-making companies with high leverage face refinancing risk; any credit deterioration could pressure the stock well below current levels
- Value trap risk: the extremely low PEG and forward P/E may reflect permanent impairment of the business model rather than a temporary dislocation, with 6 of 9 analysts already at Hold or Sell
Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.
Start free for 3 days →Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →